Letter to the Editor April 15, 2006

High-Dose Aripiprazole in Treatment-Resistant Schizophrenia

Harpeet S. Duggal, MD, DPM; Dattatreya N. Mendhekar, MD, DPM

J Clin Psychiatry 2006;67(4):674-675

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Aripiprazole, a dopamine-serotonin system stabilizer, is the latest addition to the armamentarium of antipsychotics. The maximum recommended dose for aripiprazole per the Physicians’ Desk Reference is 30 mg/day.1 However, as gleaned from recent reports, other atypical antipsychotics have been used in doses higher than those recommended by the U.S. Food and Drug Administration (FDA).2‘ ‹